IRB Approval For Human Factors Testing Is A "Judgment Call" For US Device Makers
This article was originally published in SRA
Sponsors of medical devices and combination products in the US who are required to submit human factors data to the Food and Drug Administration should take a cautious approach when deciding whether approval of an institutional review board (IRB) is needed for carrying out usability studies as there is no clear guidance on this topic.
You may also be interested in...
Swissmedic will scale back its review procedure for certain anti-infectives if the indications for which approval is being sought are identical to those approved in the EU or the US.
Based on the operational experience gained using the new international standard for reporting suspected adverse reactions in EudraVigilance, the EU has decided to set a date for its mandatory use.
The UK’s Health Research Authority has agreed in principle to implement a new policy that aims to drive a lasting change in clinical trial transparency. Not everyone is convinced.